Le Lézard
Classified in: Health, Business
Subjects: CON, FDA

Medical Coaches Awarded Contract by State of Colorado to Manufacture Mobile Opioid Clinics


ONEONTA, N.Y., July 16, 2019 /PRNewswire/ -- Medical Coaches (www.medcoach.com), a leading manufacturer of mobile medical clinics, has been selected to produce six mobile health units, specializing in medication-assisted treatment (MAT), in Colorado as part of the State's Opioid Response (SOR) Grant. Colorado was recently awarded the multi-year $30 million SOR grant from the Substance Abuse and Mental Health Services Administration to combat the State's opioid epidemic. One of the primary objectives of the SOR grant is to address the opioid crisis by increasing patient access to FDA-approved opioid reversal medication. The goal is to provide needed treatment for those with opioid dependency and reduce the growing number of opioid overdose deaths.

According to the Colorado Health Institute, overdose deaths in the state have nearly tripled since 1999, and there's been a fivefold increase in opioid-related deaths. Although access to treatment, particularly MAT, saves lives, it's estimated that more than 67,000 Coloradans who needed treatment for drug or alcohol use didn't receive it. There are a mere 22 opioid treatment providers in Colorado and they're only located in 12 of the state's 64 counties. Additionally, only 8% of providers can prescribe medical assisted treatment in the rural counties.

The overall goal of the Colorado Mobile Health project is to improve access to opioid addiction treatment in rural and underserved areas of Colorado. The mobile Medical Coaches units will break through the barriers impeding access to treatment and expand the reach of community health organization services. Medical Coaches, with a rich 70-year history of providing governments with multi-phasic health clinics, was clearly the vendor of choice for the project, as they're one of the largest specialized mobile medical unit manufacturers in the world.

"The reason Medical Coaches was chosen for this project was in part due to their longstanding history of producing quality mobile products and in part due to their amazing customer service," notes Kristy Jordon, Senior Director of Development & Communications who is one of the subcontractors working with the Colorado Department of Human Services on this project. "They listened to our needs and came up with an innovative solution that matches the mission of this project. When we were in Oneonta to tour their plant and meet the project staff, we were blown away by the high-tech production floor and the professional, yet down-to-earth and personable staff."

Chad Smith, President of Medical Coaches, adds that "We at Medical Coaches are very proud to work with the CDHS to increase access to substance abuse treatment, prevention and recovery services for people with opioid use disorder. Medical Coaches has built over 20,000 custom designed, special-purpose mobile service units for over 110 countries and all 50 United States," he points out. "We are honored to assist opioid-addicted individuals in Colorado and welcome the opportunity to provide our mobile medical units to other states seeking to help remedy the increasing opioid crisis in our country."

Media Contact: 
Chad Smith
Phone: 607-432-1333 x 125
Email: csmith@medcoach.com

Related Images

mobile-health-screening-unit.jpg

Related Links

Medical Coaches Web Site

SOURCE Medical Coaches


These press releases may also interest you

at 00:00
Dr. Angela Abraham has been appointed as the first-ever Diversity and Inclusion Liaison for the New England College of Optometry (NECO). Dr. Abraham will be leading the drive to foster a more equitable and bias-free NECO community. In a related...

9 aoû 2020
At a time when the future of the globe looks gloomy by the unabated pandemic and economic fallout, raising political hostility and anti-globalization sentiment, an online dialogue in 30th and 30st July between the civil society organizations in China...

9 aoû 2020
TopAlliance Biosciences, a wholly own subsidiary of Shanghai Junshi Biosciences (HKEX: 1877; SSE: 688180) today announced the appointment of Dr. Patricia Keegan, as Chief Medical Officer and Senior Vice President. Dr. Keegan brings over three decades...

9 aoû 2020
For the past few days, there has been immense participation by Vietnamese netizens and attention from local media for the Campaign photo, which went viral on the Internet, called "Protect Doctors 24h"....

9 aoû 2020
On August 9th, 2020, Viva Biotech (Shanghai) Co., Ltd. (hereinafter referred to as "Viva Biotech" or "The Company") entered into the Share Purchase Agreement pursuant to which Viva Biotech agreed to acquire and the Vendors agreed to collectively sell...

9 aoû 2020
Dr. Scott Sigman, principal investigator and lead author, reported today positive results from the first-ever use of laser therapy to treat a COVID-19 pneumonia patient. Published in the American Journal of Case Reports, the article shows that after...



News published on 16 july 2019 at 06:00 and distributed by: